$MDB

MERRIMAN DWIGHT A sold $3.5M of MDB

MERRIMAN DWIGHT A sold 10,000 shares of MongoDB, Inc. (MDB) at an average of $353.91 ($350.55–$354.41, $3.54M total) across 4 trades on 2026-06-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MERRIMAN DWIGHT A
Published Jun 16, 2026, 8:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 16, 2026, 8:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MDB
Neutral
medium confidence
Mentioned
$MDB
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MDBNeutralLow
01

Why it matters

A director’s open-market sale of ~10,000 shares (weighted avg ~$353.91) under a pre-arranged 10b5-1 plan is disclosed; this can slightly pressure sentiment but is usually not a standalone fundamental catalyst.

02

Market read

Traders may note the insider sale for sentiment/positioning, but the 10b5-1 framing suggests limited actionable information.

03

What to watch

The article doesn’t disclose whether other insiders or institutions changed positions around the same time, limiting signal strength.

Relevance 5/10Novelty 6/10Timing: Filed June 16; sale executed June 12.

Background

The article is an SEC Form 4 insider transaction disclosure for MongoDB, Inc. (MDB).

Company-level read

Ticker impact

$MDBNeutralMedium confidence
Context

MongoDB director sold $3.54M of MDB shares via an open-market sale under a pre-arranged 10b5-1 plan on June 12.

Expected impact

Likely limited near-term impact; any effect should be small and fade unless accompanied by other catalysts.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated 10b5-1 plan, which typically dampens inference about near-term fundamentals.

Market effects

No clear sector read-through from a single director 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

10b5-1 sales are often routine liquidity planning; the sale may not reflect bearish expectations.

Key entities

  • MongoDB, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Merriman Dwight A

    Director who sold shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MDBMed

Why MongoDB (MDB) Stock Is Up Today

MongoDB (MDB) shares rose 5.1% after CFO Mike Berry highlighted a rebound in Enterprise Advanced and continued growth in its AI-enabled Atlas cloud platform. The company reported Q2 2026 revenue of $771.8M, beating estimates, but Atlas growth remained steady at 29%, missing expectations. Shares closed at $393.88, down 1.4% YTD and 16.5% below its 52-week high.

$MDBMed

MongoDB Soars As CFO Sparks Fresh Growth Hopes

MongoDB's stock is rising due to CFO Mike Berry's optimistic remarks about the company's self-managed Enterprise Advanced business and AI-enabled Atlas cloud platform. Investors are responding to renewed confidence and institutional buying after a recent earnings-driven pullback. The company's growing Atlas user base and improving margins suggest potential for profitable scaling, but future growth depends on execution and AI initiatives.

$MDBHighAI 8/10

MongoDB (MDB) Earnings Call Highlights Growth And AI

MongoDB (MDB) reported Q2 revenue of $772M, up 30% YoY, beating guidance. Atlas cloud service grew 29% YoY, and EA offerings rose 36%. Profitability improved with non-GAAP operating income of $186M. The company raised full-year guidance, citing strong demand and AI product traction. Cash flow and customer growth also increased.

$MDBHighAI 8/10

MongoDB (MDB) Reports 30% Revenue Growth and 91% RPO Growth. Is Atlas Demand Durable Enough to Sustain Operating Leverage?

MongoDB (MDB) reported Q2 revenue of $771.8M, up 30% YoY, with Atlas revenue at $565.9M (+29%) and Enterprise Advanced at $181.2M (+36%). RPO grew 91% to $1.52B. GAAP operating income was $28.4M, vs. a $65.3M loss YoY. The company raised fiscal 2027 revenue guidance to $2.99B-$3.03B. Customer count increased to 70,600, with 69,300 Atlas customers.

$MDBMedAI 8/10

MongoDB Stock Fell 19% Despite Solid Earnings. Is it a Buy?

MongoDB reported Q2 revenue growth of 30%, exceeding guidance, with strong performance in Atlas and Enterprise Advanced. Morningstar raised its fair value estimate to $335 but maintains a 3-star rating, citing high uncertainty. Shares fell 19% after guidance raised less than expected, signaling growth deceleration.

$MDBHighAI 9/10

MongoDB (MDB) Q2 2027 Earnings Call Transcript

MongoDB (MDB) reported Q2 2027 revenue of $771.8M, up 30% YoY, driven by growth in Atlas and Enterprise Advanced. Atlas revenue grew 29.3% YoY to $565.9M. Non-GAAP operating income was $185.9M, with a 24% margin. The company added 2,900 net new customers, bringing the total to 70,600. Q3 revenue guidance is $756M-$761M, and full-year guidance was raised to $2.99B-$3.03B. Management highlighted strong AI-driven demand and multi-product adoption.